Paraneoplastic neurological syndromes

被引:108
作者
Leypoldt, F. [1 ,4 ]
Wandinger, K. -P. [2 ,3 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, D-20246 Hamburg, Germany
[2] Univ Hosp Schleswig Holstein, Inst Clin Chem, Lubeck, Germany
[3] Univ Hosp Schleswig Holstein, Dept Neurol, Lubeck, Germany
[4] August Pi I Sunyer Biomed Res Inst IDIBAPS, Catalan Inst Res & Adv Studies ICREA, Josep Dalmaus Lab, Barcelona, Spain
关键词
anti-NMDA receptor encephalitis; limbic encephalitis; paraneoplastic antibodies; paraneoplastic syndromes; CELL LUNG-CANCER; OPSOCLONUS-MYOCLONUS SYNDROME; NMDA-RECEPTOR ENCEPHALITIS; EATON MYASTHENIC SYNDROME; LIMBIC ENCEPHALITIS; PROGRESSIVE ENCEPHALOMYELITIS; CEREBELLAR DEGENERATION; CLINICAL ANALYSIS; PERIPHERAL-NERVE; MORVANS SYNDROME;
D O I
10.1111/cei.12185
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Paraneoplastic neurological syndromes are immune-mediated erroneous attacks on the central or peripheral nervous systems, or both, directed originally against the tumour itself. They have been known for more than 40 years, but recently the discovery of new subgroups of paraneoplastic encephalitis syndromes with a remarkably good response to immune therapy has ignited new clinical and scientific interest. Knowledge of these subgroups and their associated autoantibodies is important in therapeutic decision-making. However, the abundance of new autoantibodies and syndromes can be confusing. This review paper summarizes current knowledge and new developments in the field of paraneoplastic neurological syndromes, their classification, pathophysiology and treatment.
引用
收藏
页码:336 / 348
页数:13
相关论文
共 87 条
[1]  
Antoine JC, 2001, ANN NEUROL, V49, P214, DOI 10.1002/1531-8249(20010201)49:2<214::AID-ANA41>3.0.CO
[2]  
2-W
[3]   Pediatric Anti-N-methyl-D-Aspartate Receptor Encephalitis-Clinical Analysis and Novel Findings in a Series of 20 Patients [J].
Armangue, Thais ;
Titulaer, Maarten J. ;
Malaga, Ignacio ;
Bataller, Luis ;
Gabilondo, Inigo ;
Graus, Francesc ;
Dalmau, Josep .
JOURNAL OF PEDIATRICS, 2013, 162 (04) :850-+
[4]   Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus [J].
Bataller, L ;
Graus, F ;
Saiz, A ;
Vilchez, JJ .
BRAIN, 2001, 124 :437-443
[5]   Autoantigen diversity in the opsoclonus-myoclonus syndrome [J].
Bataller, L ;
Rosenfeld, MR ;
Graus, F ;
Vilchez, JJ ;
Cheung, NKV ;
Dalmau, J .
ANNALS OF NEUROLOGY, 2003, 53 (03) :347-353
[6]   Response to rituximab in 3 children with opsoclonus-myoclonus syndrome resistant to conventional treatments [J].
Battaglia, Teresa ;
De Grandis, Elisa ;
Mirabelli-Badenier, Marisol ;
Boeri, Luca ;
Morcaldi, Guido ;
Barabino, Paola ;
Intra, Chiara ;
Naselli, Francesca ;
Pistoia, Vito ;
Veneselli, Edvige ;
Conte, Massimo .
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2012, 16 (02) :192-195
[7]   GABAB receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders [J].
Boronat, A. ;
Sabater, L. ;
Saiz, A. ;
Dalmau, J. ;
Graus, F. .
NEUROLOGY, 2011, 76 (09) :795-800
[8]   Dermatomyositis [J].
Callen, Jeffrey P. ;
Wortmann, Robert L. .
CLINICS IN DERMATOLOGY, 2006, 24 (05) :363-373
[9]   Relation between dermatomyositis and polymyositis and cancer [J].
Callen, JP .
LANCET, 2001, 357 (9250) :85-86
[10]   A follow up study of patients with paraneoplastic neurological disease in the United Kingdom [J].
Candler, PM ;
Hart, PE ;
Barnett, M ;
Weil, R ;
Rees, JH .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (10) :1411-1415